Evista, Raloxifene News

Women at high risk of invasive breast cancer can elect chemoprevention with tamoxifen or raloxifene.

In postmenopausal women with osteoporosis, teriparatide and raloxifene may significantly reduce the risk of vertebral fractures, according to a study published in the June 1 issue of the Journal of Bone & Joint Surgery .

I am a woman in my mid-thirties who has undergone a radical hysterectomy because of stage 4 endometriosis.

Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.

Data presented today at the 8th European Congress on Menopause demonstrated that the majority of osteoporosis patients treated with EVISTA stay on therapy for the first two years.

Data presented today at the 8th European Congress on Menopause demonstrated that the majority of osteoporosis patients treated with raloxifene stay on therapy for the first two years.

Q: Which osteoporosis drug is the safest? I have been told to take Evista, but am hesitant because of the risk of stroke.

DEAR DR. GOTT: I was diagnosed with osteoporosis in 1998 following an abnormal bone-density test.

Dear Dr. Gott: I was diagnosed with osteoporosis in 1998 following an abnormal bone-density test.

Eli Lilly & Co.a s experimental osteoporosis drug increased bone density in spines and hips of post-menopausal women, without side effects seen in similar treatments, a study found.

The Court of Appeals for the Federal Circuit in Washington, D.C. today overturned a lower court decision and ruled in favor of Eli Lilly and Company in the case of Ariad Pharmaceuticals et al.

March 24, 2009 Eli Lilly and Company presented new data showing arzoxifene, an investigational selective estrogen receptor modulator , was superior to raloxifene at increasing bone mineral density in the lumbar spine, total hip and femoral neck, and at suppressing bone turnover as assessed by serum markers of bone metabolism.

The concerns of Ms. Kuhl and colleagues about our article and the report from which it was derived can be grouped into 3 categories: questions about how meta-analysis could find a statistically significant ...

Teva Pharmaceuticals is temporarily banned from releasing a generic version of Eli Lilly's drug.

Eli Lilly and Co. has temporarily blocked Teva Pharmaceutical Industries Ltd. from selling a cheaper generic copy of Lilly's osteoporosis drug Evista.

Eli Lilly and Co. asked a judge today to block Teva Pharmaceutical Industries Ltd.

Teva had indicated it was prepared to launch the generic version prior to the resolution of outstanding patent litigation currently being heard by the U.S. District Court for the Southern District of Indiana .

Dear Dr. Bone: I was treated for ductal carcinoma in situ non-invasive Stage 0 breast cancer and my doctor wants me to take Tamoxifen to prevent it from coming back.

Eli Lilly v. Teva Pharmaceuticals Teva is hoping to make a generic version of Lilly's Evista brand raloxifene tablets that are used to help prevent postmenopausal osteoporosis.

Judicial Review On NICE Guidance For The Primary And Secondary Prevention Of Postmenopausal Osteoporosis Main Category: Bones / Orthopaedics Also Included In: Menopause Article Date: 23 Feb 2009 - 3:00 PST ...